- Description
- Table of Contents
- Request Sample
The Global Epilepsy Therapeutics Market is expected to reach $19.31 billion by 2027 growing at a CAGR of 5.4% from 2020 to 2027. Epilepsy is a central nervous system disorder in which the brain activity becomes abnormal, thereby resulting in periods of unusual behavior or seizures, sensations, and sometimes, even loss of awareness. Epilepsy is generally diagnosed after a person has experienced at least two seizures that didn’t occur due to known medical condition; for instance, extremely low blood sugar or alcohol withdrawal. The treatment of epilepsy can be carried out with antiepileptic medications (AEDs), diet therapy, and surgery. Epilepsy therapeutics or medications are the starting treatment choice for almost all patients with multiple seizures. According to American Association of Neurological Surgeons, epilepsy therapeutics are significantly effective and completely control seizures in a majority (approximately 70%) of patients. The drugs prevent seizures by decreasing the tendency of the brain cells to send excessive and confused electrical impulses. Factors such as increasing geriatric population, adoption of anti-epileptics due to increasing seizures and epilepsy cases, and a rise in research and development in both developed and developing markets are driving the growth of the market. However, reluctance to adopt epilepsy medications in some regions is restraining the growth of the market. Based on the product, the second generation epilepsy therapeutics segment is going to have a lucrative growth during the forecast period which can be attributed to their increased penetration in the market and better effectiveness as compared to first generation epilepsy therapeutics. The key vendors mentioned are Bausch Health Companies Inc., BIAL - PORTELA & CA SA, GlaxoSmithKline Plc, Johnson & Johnson Services, Inc., Novartis AG, Pfizer Inc., SanofiSA, Sunovion Pharmaceuticals Inc., UCB SA and Zogenix Inc. Types Covered: • Anti-Epileptic Drugs • Brain Surgery • Dietary Supplements • Ketogenic Diet • Surgical Therapies • Vagal Nerve Stimulation Products Covered: • First Generation Epilepsy Therapeutics • Second Generation Epilepsy Therapeutics • Third Generation Epilepsy Therapeutics End Users Covered: • Ambulatory Surgical Centers • Home Care Settings • Hospitals & Clinics • Neurology Centers Distribution Channels Covered: • Hospital Pharmacy • Retail Pharmacy • Online Pharmacy Regions Covered: • North America • Europe • Asia Pacific • South America • Middle East & Africa Key Questions Answered in this Report: • How this market evolved since the year 2019 • Market size estimations, forecasts and CAGR for all the segments presented in the scope • Key Market Developments and financials of the key players • Opportunity Analysis for the new entrants • SWOT Analysis of the key players • Fastest growing markets analyzed during the forecast period
1 Market Synopsis
2 Research Outline
2.1 Research Snapshot
2.2 Research Methodology
2.3 Research Sources
2.3.1 Primary Research Sources
2.3.2 Secondary Research Sources
3 Market Dynamics
3.1 Drivers
3.2 Restraints
4 Market Environment
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Epilepsy Therapeutics Market, By Type
5.1 Introduction
5.2 Anti-Epileptic Drugs
5.3 Brain Surgery
5.4 Dietary Supplements
5.5 Ketogenic Diet
5.6 Surgical Therapies
5.7 Vagal Nerve Stimulation
6 Global Epilepsy Therapeutics Market, By Product
6.1 Introduction
6.2 First Generation Epilepsy Therapeutics
6.3 Second Generation Epilepsy Therapeutics
6.4 Third Generation Epilepsy Therapeutics
7 Global Epilepsy Therapeutics Market, By End User
7.1 Introduction
7.2 Ambulatory Surgical Centers
7.3 Home Care Settings
7.4 Hospitals & Clinics
7.5 Neurology Centers
8 Global Epilepsy Therapeutics Market, By Distribution Channel
8.1 Introduction
8.2 Hospital Pharmacy
8.3 Retail Pharmacy
8.4 Online Pharmacy
9 Global Epilepsy Therapeutics Market, By Geography
9.1 Introduction
9.2 North America
9.3 Europe
9.4 Asia Pacific
9.5 South America
9.6 Middle East & Africa
10 Strategic Benchmarking
11 Vendors Landscape
11.1 Bausch Health Companies Inc.
11.2 BIAL – PORTELA & CA SA
11.3 GlaxoSmithKline Plc
11.4 Johnson & Johnson Services, Inc.
11.5 Novartis AG
11.6 Pfizer Inc.
11.7 SanofiSA
11.8 Sunovion Pharmaceuticals Inc.
11.9 UCB SA
11.10 Zogenix Inc.
List of Data Tables
1 Global Epilepsy Therapeutics Market Outlook, By Region (2019-2027) ($MN)
2 Global Epilepsy Therapeutics Market Outlook, By Type (2019-2027) ($MN)
3 Global Epilepsy Therapeutics Market Outlook, By Anti-Epileptic Drugs (2019-2027) ($MN)
4 Global Epilepsy Therapeutics Market Outlook, By Brain Surgery (2019-2027) ($MN)
5 Global Epilepsy Therapeutics Market Outlook, By Dietary Supplements (2019-2027) ($MN)
6 Global Epilepsy Therapeutics Market Outlook, By Ketogenic Diet (2019-2027) ($MN)
7 Global Epilepsy Therapeutics Market Outlook, By Surgical Therapies (2019-2027) ($MN)
8 Global Epilepsy Therapeutics Market Outlook, By Vagal Nerve Stimulation (2019-2027) ($MN)
9 Global Epilepsy Therapeutics Market Outlook, By Product (2019-2027) ($MN)
10 Global Epilepsy Therapeutics Market Outlook, By First Generation Epilepsy Therapeutics (2019-2027) ($MN)
11 Global Epilepsy Therapeutics Market Outlook, By Second Generation Epilepsy Therapeutics (2019-2027) ($MN)
12 Global Epilepsy Therapeutics Market Outlook, By Third Generation Epilepsy Therapeutics (2019-2027) ($MN)
13 Global Epilepsy Therapeutics Market Outlook, By End User (2019-2027) ($MN)
14 Global Epilepsy Therapeutics Market Outlook, By Ambulatory Surgical Centers (2019-2027) ($MN)
15 Global Epilepsy Therapeutics Market Outlook, By Home Care Settings (2019-2027) ($MN)
16 Global Epilepsy Therapeutics Market Outlook, By Hospitals & Clinics (2019-2027) ($MN)
17 Global Epilepsy Therapeutics Market Outlook, By Neurology Centers (2019-2027) ($MN)
18 Global Epilepsy Therapeutics Market Outlook, By Distribution Channel (2019-2027) ($MN)
19 Global Epilepsy Therapeutics Market Outlook, By Hospital Pharmacy (2019-2027) ($MN)
20 Global Epilepsy Therapeutics Market Outlook, By Retail Pharmacy (2019-2027) ($MN)
21 Global Epilepsy Therapeutics Market Outlook, By Online Pharmacy (2019-2027) ($MN)
22 North America Epilepsy Therapeutics Market Outlook, By Type (2019-2027) ($MN)
23 North America Epilepsy Therapeutics Market Outlook, By Product (2019-2027) ($MN)
24 North America Epilepsy Therapeutics Market Outlook, By End User (2019-2027) ($MN)
25 North America Epilepsy Therapeutics Market Outlook, By Distribution Channel (2019-2027) ($MN)
26 Europe Epilepsy Therapeutics Market Outlook, By Type (2019-2027) ($MN)
27 Europe Epilepsy Therapeutics Market Outlook, By Product (2019-2027) ($MN)
28 Europe Epilepsy Therapeutics Market Outlook, By End User (2019-2027) ($MN)
29 Europe Epilepsy Therapeutics Market Outlook, By Distribution Channel (2019-2027) ($MN)
30 Asia Pacific Epilepsy Therapeutics Market Outlook, By Type (2019-2027) ($MN)
31 Asia Pacific Epilepsy Therapeutics Market Outlook, By Product (2019-2027) ($MN)
32 Asia Pacific Epilepsy Therapeutics Market Outlook, By End User (2019-2027) ($MN)
33 Asia Pacific Epilepsy Therapeutics Market Outlook, By Distribution Channel (2019-2027) ($MN)
34 South America Epilepsy Therapeutics Market Outlook, By Type (2019-2027) ($MN)
35 South America Epilepsy Therapeutics Market Outlook, By Product (2019-2027) ($MN)
36 South America Epilepsy Therapeutics Market Outlook, By End User (2019-2027) ($MN)
37 South America Epilepsy Therapeutics Market Outlook, By Distribution Channel (2019-2027) ($MN)
38 Middle East & Africa Epilepsy Therapeutics Market Outlook, By Type (2019-2027) ($MN)
39 Middle East & Africa Epilepsy Therapeutics Market Outlook, By Product (2019-2027) ($MN)
40 Middle East & Africa Epilepsy Therapeutics Market Outlook, By End User (2019-2027) ($MN)
41 Middle East & Africa Epilepsy Therapeutics Market Outlook, By Distribution Channel (2019-2027) ($MN)